Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Roni M. Cox's research centers on the pathological examination of neoplasms, with a particular focus on genitourinary cancers. Cox has investigated the impact of neoadjuvant chemotherapy on pathologic downstaging in patients with variant histology undergoing radical cystectomy, a study co-authored with Neriman Gökden. Additional publications explore atypical intraductal proliferation in prostate needle core biopsies, myxoid pseudotumors involving the renal sinus, and testicular germ-cell tumors with spermatic cord involvement. Cox also examines clear cell adenocarcinoma of the urinary tract, studying its clinical and molecular characteristics. With an h-index of 11 and 27 publications, Cox's work contributes to the understanding and diagnosis of various cancers.
Metrics
- h-index: 12
- Publications: 27
- Citations: 549
Selected Publications
-
Detection of human papillomavirus with low-risk chromogenic in situ hybridization probes in seborrheic keratosis-like lesions of the male genital tract (2026)
-
Atypical Intraductal Proliferation in Prostate Needle Core Biopsy (2025)
Collaboration Network
Top Collaborators
- Atypical Intraductal Proliferation in Prostate Needle Core Biopsy
- Myxoid Pseudotumor Involving the Renal Sinus
- Distal Tubular Hyperplasia
- Atypical Intraductal Proliferation in Prostate Needle Core Biopsy
- Myxoid Pseudotumor Involving the Renal Sinus
- Distal Tubular Hyperplasia
- Atypical Intraductal Proliferation in Prostate Needle Core Biopsy
- Distal Tubular Hyperplasia
- Distal Tubular Hyperplasia
- Clinical and Molecular Characterization of Clear Cell Adenocarcinoma of the Urinary Tract
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
- Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
- PD51-03 IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY
Similar Researchers
Based on overlapping research topics